M&A / Deals BioAegis and Prenosis partner for inflammatory disease therapies Pharmaceutical TechnologyBioAegis Therapeutics has entered a strategic partnership with Prenosis to advance AI-driven precision medicine for inflammatory diseases.M&A / DealsImmunology & InflammationRead full story pharminent April 22, 2026 (Last updated: April 22, 2026) Pharmaceutical Technology BioAegis Therapeutics has entered a strategic partnership with Prenosis to advance AI-driven precision medicine for inflammatory diseases. M&A / DealsImmunology & InflammationRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Medicare obesity drug pilot extended after insurer pushbackNext: BioAegis and Prenosis partner for inflammatory disease therapies Related Stories M&A / Deals Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar pharminent July 10, 2026 M&A / Deals GSK ends dementia alliance with Alector after setbacks pharminent July 9, 2026 M&A / Deals AstraZeneca, GSK intensify China ties with Sino Biopharm deals pharminent July 8, 2026
